On November 14, 2012, The Clorox Company (the "Company") held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:

1. The Company's stockholders re-elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.

                                                Number of Votes
                              For          Against      Abstain     Broker Non-Votes
Daniel Boggan, Jr.         85,253,336      750,213      413,292        26,213,025
Dr. Richard H. Carmona     83,859,628     2,156,176     401,036        26,213,025
Tully M. Friedman          83,897,752     2,127,498     391,591        26,213,025
George J. Harad            84,261,758     1,759,865     394,813        26,213,025
Donald R. Knauss           83,737,863     2,274,999     403,574        26,213,025
Robert W. Matschullat      83,933,382     2,092,313     390,741        26,213,025
Edward A. Mueller          85,340,080      689,067      387,694        26,213,025
Pamela Thomas-Graham       85,698,865      335,403      382,573        26,213,025
Carolyn M. Ticknor         85,468,882      566,460      381,499        26,213,025

2. The Company's stockholders voted for (on an advisory basis) the compensation of the Company's named executive officers.

Number of Votes For Against Abstain Broker Non-Votes 81,770,799 3,478,574 1,167,468 26,213,025

3. The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2013.

Number of Votes For Against Abstain Broker Non-Votes 111,377,719 738,358 513,789 0

4. The Company's stockholders voted for the approval of the amended and restated 2005 stock incentive plan.

Number of Votes For Against Abstain Broker Non-Votes 72,070,278 13,729,869 616,694 26,213,025